BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 27732819)

  • 21. Performance of the GeneXpert Ebola Assay for Diagnosis of Ebola Virus Disease in Sierra Leone: A Field Evaluation Study.
    Semper AE; Broadhurst MJ; Richards J; Foster GM; Simpson AJ; Logue CH; Kelly JD; Miller A; Brooks TJ; Murray M; Pollock NR
    PLoS Med; 2016 Mar; 13(3):e1001980. PubMed ID: 27023868
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-Ebola Virus Antibody Levels in Convalescent Plasma and Viral Load After Plasma Infusion in Patients With Ebola Virus Disease.
    Brown JF; Dye JM; Tozay S; Jeh-Mulbah G; Wohl DA; Fischer WA; Cunningham CK; Rowe K; Zacharias P; van Hasselt J; Norwood DA; Thielman NM; Zak SE; Hoover DL
    J Infect Dis; 2018 Jul; 218(4):555-562. PubMed ID: 29659889
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of Convalescent Plasma for Ebola Virus Disease in Guinea.
    van Griensven J; Edwards T; de Lamballerie X; Semple MG; Gallian P; Baize S; Horby PW; Raoul H; Magassouba N; Antierens A; Lomas C; Faye O; Sall AA; Fransen K; Buyze J; Ravinetto R; Tiberghien P; Claeys Y; De Crop M; Lynen L; Bah EI; Smith PG; Delamou A; De Weggheleire A; Haba N;
    N Engl J Med; 2016 Jan; 374(1):33-42. PubMed ID: 26735992
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Contribution of Ebola Viral Load at Admission and Other Patient Characteristics to Mortality in a Médecins Sans Frontières Ebola Case Management Centre, Kailahun, Sierra Leone, June-October 2014.
    Fitzpatrick G; Vogt F; Moi Gbabai OB; Decroo T; Keane M; De Clerck H; Grolla A; Brechard R; Stinson K; Van Herp M
    J Infect Dis; 2015 Dec; 212(11):1752-8. PubMed ID: 26002981
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute rhabdomyolysis and delayed pericardial effusion in an Italian patient with Ebola virus disease: a case report.
    Nicastri E; Brucato A; Petrosillo N; Biava G; Uyeki TM; Ippolito G;
    BMC Infect Dis; 2017 Aug; 17(1):597. PubMed ID: 28854896
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characteristics and survival of patients with Ebola virus infection, malaria, or both in Sierra Leone: a retrospective cohort study.
    Waxman M; Aluisio AR; Rege S; Levine AC
    Lancet Infect Dis; 2017 Jun; 17(6):654-660. PubMed ID: 28258817
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ebola virus disease complicated with viral interstitial pneumonia: a case report.
    Petrosillo N; Nicastri E; Lanini S; Capobianchi MR; Di Caro A; Antonini M; Puro V; Lauria FN; Shindo N; Magrini N; Kobinger GP; Ippolito G;
    BMC Infect Dis; 2015 Oct; 15():432. PubMed ID: 26471197
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A 6-Year-Old Child with Severe Ebola Virus Disease: Laboratory-Guided Clinical Care in an Ebola Treatment Center in Guinea.
    Palich R; Gala JL; Petitjean F; Shepherd S; Peyrouset O; Abdoul BM; Kinda M; Danel C; Augier A; Anglaret X; Malvy D; Blackwell N;
    PLoS Negl Trop Dis; 2016 Mar; 10(3):e0004393. PubMed ID: 27011342
    [No Abstract]   [Full Text] [Related]  

  • 29. Two-mAb cocktail protects macaques against the Makona variant of Ebola virus.
    Qiu X; Audet J; Lv M; He S; Wong G; Wei H; Luo L; Fernando L; Kroeker A; Fausther Bovendo H; Bello A; Li F; Ye P; Jacobs M; Ippolito G; Saphire EO; Bi S; Shen B; Gao GF; Zeitlin L; Feng J; Zhang B; Kobinger GP
    Sci Transl Med; 2016 Mar; 8(329):329ra33. PubMed ID: 26962157
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical features of suspected Ebola cases referred to the Moyamba ETC, Sierra Leone: challenges in the later stages of the 2014 outbreak.
    Arranz J; Lundeby KM; Hassan S; Zabala Fuentes LM; San José Garcés P; Haaskjold YL; Bolkan HA; Krogh KØ; Jongopi J; Mellesmo S; Jøsendal O; Øpstad Å; Svensen E; Kamara AS; Roberts DP; Stamper PD; Austin P; Moosa AJ; Marke D; Berg Å; Blomberg B; Riera M
    BMC Infect Dis; 2016 Jun; 16():308. PubMed ID: 27334891
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Experimental Treatment of Ebola Virus Disease with TKM-130803: A Single-Arm Phase 2 Clinical Trial.
    Dunning J; Sahr F; Rojek A; Gannon F; Carson G; Idriss B; Massaquoi T; Gandi R; Joseph S; Osman HK; Brooks TJ; Simpson AJ; Goodfellow I; Thorne L; Arias A; Merson L; Castle L; Howell-Jones R; Pardinaz-Solis R; Hope-Gill B; Ferri M; Grove J; Kowalski M; Stepniewska K; Lang T; Whitehead J; Olliaro P; Samai M; Horby PW;
    PLoS Med; 2016 Apr; 13(4):e1001997. PubMed ID: 27093560
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A systematic review of Ebola virus disease outbreaks and an analysis of the efficacy and safety of newer drugs approved for the treatment of Ebola virus disease by the US Food and Drug Administration from 2016 to 2020.
    Sivanandy P; Jun PH; Man LW; Wei NS; Mun NFK; Yii CAJ; Ying CCX
    J Infect Public Health; 2022 Mar; 15(3):285-292. PubMed ID: 35085865
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ebola virus disease in the Democratic Republic of Congo.
    Maganga GD; Kapetshi J; Berthet N; Kebela Ilunga B; Kabange F; Mbala Kingebeni P; Mondonge V; Muyembe JJ; Bertherat E; Briand S; Cabore J; Epelboin A; Formenty P; Kobinger G; González-Angulo L; Labouba I; Manuguerra JC; Okwo-Bele JM; Dye C; Leroy EM
    N Engl J Med; 2014 Nov; 371(22):2083-91. PubMed ID: 25317743
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A meta-analysis of clinical studies conducted during the West Africa Ebola virus disease outbreak confirms the need for randomized control groups.
    Dodd LE; Follmann D; Proschan M; Wang J; Malvy D; van Griensven J; Ciglenecki I; Horby PW; Ansumana R; Jiang JF; Davey RT; Lane HC; Gouel-Cheron A
    Sci Transl Med; 2019 Nov; 11(520):. PubMed ID: 31776287
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model.
    Oestereich L; Lüdtke A; Wurr S; Rieger T; Muñoz-Fontela C; Günther S
    Antiviral Res; 2014 May; 105():17-21. PubMed ID: 24583123
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ebola management centre proximity associated with reduced delays of healthcare of Ebola Virus Disease (EVD) patients, Tonkolili, Sierra Leone, 2014-15.
    Theocharopoulos G; Danis K; Greig J; Hoffmann A; De Valk H; Jimissa A; Tejan S; Sankoh M; Kleijer K; Turner W; Achar J; Duncombe J; Lokuge K; Gayton I; Broeder R; Kremer R; Caleo G
    PLoS One; 2017; 12(5):e0176692. PubMed ID: 28459838
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gene Transfer of ZMapp Antibodies Mediated by Recombinant Adeno-Associated Virus Protects Against Ebola Infections.
    Robert MA; Nassoury N; Chahal PS; Venne MH; Racine T; Qiu X; Kobinger G; Kamen A; Gilbert R; Gaillet B
    Hum Gene Ther; 2018 Apr; 29(4):452-466. PubMed ID: 29179602
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical care of two patients with Ebola virus disease in the United States.
    Lyon GM; Mehta AK; Varkey JB; Brantly K; Plyler L; McElroy AK; Kraft CS; Towner JS; Spiropoulou C; Ströher U; Uyeki TM; Ribner BS;
    N Engl J Med; 2014 Dec; 371(25):2402-9. PubMed ID: 25390460
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The ongoing evolution of antibody-based treatments for Ebola virus infection.
    Mendoza EJ; Racine T; Kobinger GP
    Immunotherapy; 2017 Mar; 9(5):435-450. PubMed ID: 28357917
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Statistical considerations for a trial of Ebola virus disease therapeutics.
    Proschan MA; Dodd LE; Price D
    Clin Trials; 2016 Feb; 13(1):39-48. PubMed ID: 26768567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.